CD73 compounds
US11919869B2 · kind B2 · utility
0Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2022 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | Oct 27, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein is A compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.